An announcement from Moleculin Biotech ( ($MBRX) ) is now available. On July 9, 2025, Moleculin Biotech announced that the Regulation Agency for ...

Career scope in Biotechnology. Today we see amazing discoveries, new applications and innovative products on the market every day. The demand for biotechnologists is very high in various segments ...

This isn't the only catalyst coming out which could change the scope of this biotech. It is expected that FibroGen will report results from the phase 3 ZEPHYRUS-1 study in mid-2023.

My Green Lab's 2024 report reveals growing climate commitments from the biotech and pharma sectors while underscoring the urgency of accelerating Scope 3 emissions reductions. BAKU, AZERBAIJAN ...

Dianthus Therapeutics, Inc. (NASDAQ:DNTH), a clinical-stage biotechnology company listed on the Nasdaq Composite Russell 1000 ...

Brain-focused Neurocrine buys a biotech to broaden its scope in hormone disorders Neurocrine Biosciences is acquiring Diurnal Group, a U.K-based biotech that has commercialized two endocrine ...

Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes new concepts in technology/methodology of relevance to the biological, biomedical ...

6.1a Congress must include biotechnology in the scope of the U.S. Department of State’s International Technology Security and Innovation Fund to fund appropriately international biotechnology ...

The biotech sector has an outsize economic impact on the state, providing an average salary of almost $200,000 a year, according to MassBio, and driving growth in real estate, construction, and ...